Oruka Therapeutics (ORKA) EPS (Diluted) Growth (3y) (2013 - 2024)
Oruka Therapeutics (ORKA) EPS (Diluted) Growth (3y) (2013 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 78.99% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 37.28% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.39% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -2.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 83.94% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Oruka Therapeutics | 36.09 Mn | -795.06 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -54.87% |
| Mar 31, 2024 | 87.63% |
| Dec 31, 2023 | 93.81% |
| Sep 30, 2023 | 90.04% |
| Jun 30, 2023 | 89.06% |
| Mar 31, 2023 | 89.47% |
| Dec 31, 2022 | 89.77% |
| Sep 30, 2022 | 86.77% |
| Jun 30, 2022 | 85.84% |
| Mar 31, 2022 | 86.96% |
| Dec 31, 2021 | 83.60% |
| Sep 30, 2021 | 85.11% |
| Jun 30, 2021 | 86.34% |
| Mar 31, 2021 | -14.51% |
| Dec 31, 2020 | -7.19% |
| Sep 30, 2020 | 23.42% |
| Jun 30, 2020 | 38.52% |
| Mar 31, 2020 | 33.15% |
| Dec 31, 2019 | 34.02% |
| Sep 30, 2019 | 37.53% |